You have successfully sign out
Loading...
Cyclo Therapeutics, Inc.
CYTHW
Company Description
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
Â
NASDAQ
0.09USD
-0.03Â ( -23.33%)Market Closed (as of Mar 21, 20:00 EDT)
Relative Strenght
18
Volume Buzz
-82%
Earning Acce
No
Dist 52w H.
85%
